Key Data

 

 

2016

 

2017

 

Change

 

 

€ million

 

€ million

 

%

2016 figures restated

1

For definitions of the indicators see Chapter “Alternative Performance Measures Used by the Bayer Group.”

2

Group total 2016 including Covestro

3

Employees calculated as full-time equivalents (FTEs)

4

Number of incidents in which chemicals leak from their primary container, such as pipelines, pumps, tanks or drums, per 200,000 working hours

5

Quotient of total energy consumption and manufactured sales volume; Bayer excluding Currenta

6

Direct emissions from power plants, waste incinerators and production plants and indirect emissions from external supplies of electricity, steam and cooling (according to the market-based method); portfolio-adjusted in accordance with the GHG Protocol

7

Bayer excluding Currenta

Bayer Group

 

 

 

 

 

 

Sales

 

34,943

 

35,015

 

+0.2%

EBITDA1

 

8,801

 

8,563

 

−2.7%

EBITDA before special items1

 

9,318

 

9,288

 

−0.3%

EBITDA margin before special items1

 

26.7%

 

26.5%

 

 

EBIT1

 

5,738

 

5,903

 

+2.9%

EBIT before special items1

 

6,826

 

7,130

 

+4.5%

Income before income taxes

 

4,773

 

4,577

 

−4.1%

Net income (from continuing and discontinued operations)

 

4,531

 

7,336

 

+61.9%

Earnings per share (from continuing and discontinued operations) (€)1

 

5.44

 

8.41

 

+54.6%

Core earnings per share (from continuing operations) (€)1

 

6.67

 

6.74

 

+1.0%

Net cash provided by operating activities (from continuing and discontinued operations)

 

9,089

 

8,134

 

−10.5%

Net financial debt

 

11,778

 

3,595

 

−69.5%

Capital expenditures as per segment table2

 

2,627

 

2,418

 

−8.0%

 

 

 

 

 

 

 

Bayer AG

 

 

 

 

 

 

Total dividend payment

 

2,233

 

2,315

 

+3.7%

Dividend per share (€)

 

2.70

 

2.80

 

+3.7%

 

 

 

 

 

 

 

Innovation

 

 

 

 

 

 

Research and development expenses

 

4,405

 

4,504

 

+2.2%

Ratio of R&D expenses to sales – Pharmaceuticals (%)

 

16.7

 

16.2

 

 

Ratio of R&D expenses to sales – Crop Science (%)

 

11.7

 

11.7

 

 

Employees in research and development

 

14,213

 

14,041

 

−1.2%

 

 

 

 

 

 

 

Employees

 

 

 

 

 

 

Number of employees3 (Dec. 31)

 

99,592

 

99,820

 

+0.2%

Personnel expenses (including pension expenses) (€ million)

 

9,459

 

9,528

 

+0.7%

Proportion of women in senior management (%)

 

31

 

32

 

 

Proportion of employees with health insurance (%)

 

98

 

98

 

 

Fluctuation (voluntary / total) (%)

 

4.8 / 13.2

 

4.8 / 10.4

 

 

Hours of vocational and ongoing training per employee

 

23.0

 

23.4

 

+1.7%

 

 

 

 

 

 

 

Safety & Environmental Protection

 

 

 

 

 

 

Recordable Incident Rate (RIR) for Bayer employees

 

0.40

 

0.45

 

+12.5%

Loss of Primary Containment Incident Rate (LoPC-IR)4

 

0.17

 

0.13

 

−21.4%

Total energy consumption (terajoules)

 

26,243

 

25,832

 

−1.6%

Energy efficiency (kWh / €1,000 external sales)5

 

130

 

125

 

−3.8%

Total greenhouse gas emissions (CO2 equivalents in million t)6

 

4.64

 

3.63

 

−21.8%

Specific greenhouse gas emissions (kg CO2 equivalents / €1,000 external sales) according to the market-based method7

 

48.45

 

46.26

 

−4.5%

Water use (million m3)

 

93

 

98

 

+6.0%

Compare to Last Year